DK0801571T3 - Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer - Google Patents
Opløselige 2'-chlor-2'-deoxyadenosion-formuleringerInfo
- Publication number
- DK0801571T3 DK0801571T3 DK95943134T DK95943134T DK0801571T3 DK 0801571 T3 DK0801571 T3 DK 0801571T3 DK 95943134 T DK95943134 T DK 95943134T DK 95943134 T DK95943134 T DK 95943134T DK 0801571 T3 DK0801571 T3 DK 0801571T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulations
- deoxyadenosion
- chloro
- soluble
- cda
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36208394A | 1994-12-22 | 1994-12-22 | |
| PCT/US1995/016418 WO1996019230A1 (en) | 1994-12-22 | 1995-12-15 | Soluble 2-chloro-2'-deoxyadenosine formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0801571T3 true DK0801571T3 (da) | 2003-01-06 |
Family
ID=23424634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95943134T DK0801571T3 (da) | 1994-12-22 | 1995-12-15 | Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5681822A (da) |
| EP (1) | EP0801571B1 (da) |
| JP (1) | JPH10512549A (da) |
| AT (1) | ATE223221T1 (da) |
| CA (1) | CA2208484C (da) |
| CZ (1) | CZ194297A3 (da) |
| DE (1) | DE69528080T2 (da) |
| DK (1) | DK0801571T3 (da) |
| ES (1) | ES2182920T3 (da) |
| HU (1) | HUT77928A (da) |
| IL (1) | IL116469A0 (da) |
| PL (1) | PL321431A1 (da) |
| PT (1) | PT801571E (da) |
| WO (1) | WO1996019230A1 (da) |
| ZA (1) | ZA9510924B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166525A1 (en) * | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| US6194395B1 (en) * | 1999-02-25 | 2001-02-27 | Orthro-Mcneil Pharmaceutical, Inc. | Cyclodextrin cladribine formulations |
| MXPA05010635A (es) * | 2003-04-02 | 2005-12-12 | Ares Trading Sa | Formulaciones farmaceuticas liquidas de hormona estimulante de foliculos y hormona luteinizante junto con un surfactante no ionico. |
| WO2004112826A1 (en) * | 2003-06-20 | 2004-12-29 | Ares Trading Sa | Freeze-dried fsh / lh formulations |
| FR2873695A1 (fr) * | 2004-07-30 | 2006-02-03 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien |
| DK2805723T3 (da) | 2004-12-22 | 2018-01-29 | Merck Serono Sa | Cladribin-regime til behandling af multipel sclerose |
| MX2008014971A (es) | 2006-05-24 | 2008-12-05 | Serono Lab | Regimen de cladribine para tratar esclerosis multiple. |
| EP2343074A1 (en) | 2009-12-23 | 2011-07-13 | Merck Serono S.A. | Use of purine analogues for treating airway diseases |
| CN111356460A (zh) | 2017-11-24 | 2020-06-30 | 默克专利股份公司 | 用于治疗进展型形式的多发性硬化症的克拉屈滨疗法 |
| CA3194812A1 (en) | 2020-09-10 | 2022-03-17 | Merck Patent Gmbh | Novel treatment regimen for the treatment of autoimmune disorders |
| US20240077481A1 (en) | 2021-03-03 | 2024-03-07 | Ares Trading S.A. | Improved treatment methods using dmds for the treatment of autoimmune diseases, and biomarker for predicting and/or optimising said treatment methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826823A (en) * | 1985-02-05 | 1989-05-02 | Warner-Lambert Company | Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts |
| US4719295A (en) * | 1985-12-31 | 1988-01-12 | Warner-Lambert Company | Compound 2-iodo-2'-deoxyadenosine |
| US5310732A (en) * | 1986-02-03 | 1994-05-10 | The Scripps Research Institute | 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis |
| US4908441A (en) * | 1988-07-19 | 1990-03-13 | Warner-Lambert Company | Deoxyadenosine compounds and methods of making and using the same |
| US5208327A (en) * | 1991-12-18 | 1993-05-04 | Ortho Pharmaceutical Corporation | Intermediates useful in a synthesis of 2-chloro-2'-deoxyadenosine |
| EP0642347A4 (en) * | 1992-05-19 | 1997-06-18 | Scripps Research Inst | USE OF 2-HALO-ADENINE DERIVATIVES AS THERAPEUTIC ACTIVE AGENTS AGAINST CHRONIC-MYELOIC LEUKEMIA. |
-
1995
- 1995-12-15 PT PT95943134T patent/PT801571E/pt unknown
- 1995-12-15 WO PCT/US1995/016418 patent/WO1996019230A1/en not_active Ceased
- 1995-12-15 DE DE69528080T patent/DE69528080T2/de not_active Expired - Lifetime
- 1995-12-15 CZ CZ971942A patent/CZ194297A3/cs unknown
- 1995-12-15 ES ES95943134T patent/ES2182920T3/es not_active Expired - Lifetime
- 1995-12-15 JP JP8519914A patent/JPH10512549A/ja active Pending
- 1995-12-15 CA CA002208484A patent/CA2208484C/en not_active Expired - Lifetime
- 1995-12-15 EP EP95943134A patent/EP0801571B1/en not_active Expired - Lifetime
- 1995-12-15 AT AT95943134T patent/ATE223221T1/de active
- 1995-12-15 PL PL95321431A patent/PL321431A1/xx unknown
- 1995-12-15 HU HU9801007A patent/HUT77928A/hu unknown
- 1995-12-15 DK DK95943134T patent/DK0801571T3/da active
- 1995-12-20 IL IL11646995A patent/IL116469A0/xx unknown
- 1995-12-21 ZA ZA9510924A patent/ZA9510924B/xx unknown
-
1997
- 1997-01-10 US US08/781,438 patent/US5681822A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5681822A (en) | 1997-10-28 |
| ES2182920T3 (es) | 2003-03-16 |
| EP0801571B1 (en) | 2002-09-04 |
| CZ194297A3 (en) | 1997-10-15 |
| WO1996019230A1 (en) | 1996-06-27 |
| EP0801571A1 (en) | 1997-10-22 |
| DE69528080T2 (de) | 2003-06-05 |
| ATE223221T1 (de) | 2002-09-15 |
| IL116469A0 (en) | 1996-03-31 |
| JPH10512549A (ja) | 1998-12-02 |
| HUT77928A (hu) | 1998-11-30 |
| PT801571E (pt) | 2002-12-31 |
| CA2208484C (en) | 2008-09-23 |
| DE69528080D1 (de) | 2002-10-10 |
| PL321431A1 (en) | 1997-12-08 |
| CA2208484A1 (en) | 1996-06-27 |
| ZA9510924B (en) | 1997-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9510865B (en) | Stable 2-chloro-2'-deoxyadenosine formulations | |
| PL300194A1 (en) | Interferon conjugate, method of obtaining same and pharmaceutical composition containing it | |
| TR199700358A2 (xx) | �nterferon birle�imler. | |
| ITRM920476A0 (it) | Formulazioni galeniche contenenti ciclosporina. | |
| MY131095A (en) | Polyethylene protein conjugates. | |
| TR199500778A1 (tr) | Suda risperidon formülasyonlari. | |
| ATE257014T1 (de) | Lichtbilderzeugungskontrastmitteln | |
| FI972514L (fi) | Kasvainspesifisten sytotoksisten T-solujen in vivo aktivointi | |
| ATE244015T1 (de) | Formulierungen fuer faktor ix | |
| PT932397E (pt) | Formulacoes em aerossol medicinais compreendendo budesonida | |
| FI921142L (fi) | Gelformulationer. | |
| NO993028D0 (no) | Vannbaserte alkoholhydroksykarboksylperoksid-sammensetninger, fremstilling og anvendelse herav | |
| TR199600499A2 (tr) | S(+)-Etodolak'in oral formülasyonlari. | |
| DK0801571T3 (da) | Opløselige 2'-chlor-2'-deoxyadenosion-formuleringer | |
| ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
| DZ1926A1 (fr) | Formulations pharmaceutiques. | |
| JO1907B1 (en) | Dissolved compounds of 2-chloro-2-dioxin adenosine | |
| EP0923366A4 (en) | SUN PROTECTOR CONTAINING DAMAGED RNS FRAGMENTS | |
| JO1908B1 (en) | Static compounds of 2-chloro-2-dioxin adenosine | |
| IT1254452B (it) | N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli | |
| RU96103721A (ru) | Антгельминтное средство | |
| CA2208241A1 (en) | Stable solutions of 2-chloro-2'-deoxyadenosine formulations | |
| TR199701011A2 (xx) | 1-karba-(detia)-sefalosforin t�revleri. | |
| MA22854A1 (fr) | Conjugues de proteine et de polyethylene glycol . | |
| IT1288577B1 (it) | Struttura di supporto, in particolare composita da attacchi per monosci |